Yinjun Lou

机构：Zhejiang Cancer Hospital, Zhejiang Technical Institute of Economics, Zhejiang Lab, First Affiliated Hospital Zhejiang University, Zhejiang University · ORCID：0000-0003-4495-2460

发表论文 133 篇 · 总被引 1872 次 · h-index 25

代表论文

• LBA3 Perioperative pembrolizumab (pembro) plus neoadjuvant chemotherapy (chemo) in early-stage non-small-cell lung cancer (NSCLC): A 4-year update of KEYNOTE-671 (2024 · Immuno-Oncology Technology · 被引 8)
• Characteristics and predictors of central nervous system relapse in newly diagnosed acute promyelocytic leukemia in the era of arsenic: a 13-year monocenter cohort study (2025 · Blood Cancer Journal · 被引 6)
• Olverembatinib plus immunotherapy versus olverembatinib plus allogeneic hematopoietic cell transplantation in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (2026 · Blood Cancer Journal · 被引 1)
• Venetoclax and Homoharringtonine‐Based Therapy Exhibited a Striking Response in Refractory/Relapsed Early T‐Cell Precursor Acute Lymphoblastic Leukemia (2025 · MedComm · 被引 1)
• Efficacy of short-course versus standard-course blinatumomab in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia (2025 · Blood · 被引 1)
• Orelabrutinib Combined with Bendamustine-Rituximab or Obinutuzumab Followed By Orelabrutinib Maintenance Therapy for Untreated Marginal Zone Lymphoma (MZL): A Prospective ,Multicenter, Clinical Study（Optimize Study） (2024 · Blood · 被引 1)